Immix Biopharma (IMMX) Interest Coverage Ratio (2021 - 2026)
Immix Biopharma (IMMX) posted Interest Coverage Ratio of 30.29 for Q1 2026, down 5.02% sequentially from 28.84 in Q4 2025, and down 182.38% YoY from 36.77 in Q1 2025.
Immix Biopharma (IMMX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Immix Biopharma has reported Interest Coverage Ratio for 6 years, with the latest figure at 30.29 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 182.38% year-over-year to 30.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101.15 (down 102.86% YoY) and the FY2025 annual result came in at 1.18, up 17.65% from the prior year.
- Interest Coverage Ratio retreated to 30.29 in Q1 2026 per IMMX's latest filing, from 28.84 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 417.03 in Q4 2022 and troughed at 8259.02 in Q2 2022.
- A 5-year average of 875.41 and a median of 10.7 in 2024 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 161.68% in 2022, down 182850.63% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 417.03 in 2022, then tumbled by 100.17% to 0.7 in 2023, then soared by 55.09% to 0.32 in 2024, then tumbled by 9017.25% to 28.84 in 2025, then decreased by 5.02% to 30.29 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 30.29, 28.84, and 5.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - | -9.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.31 |
| Mar 31, 2026 | -30.29 |
| Dec 31, 2025 | -28.84 |
| Sep 30, 2025 | -5.09 |
| Jun 30, 2025 | -16.16 |
| Mar 31, 2025 | -10.73 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -4.72 |
| Jun 30, 2024 | -2.93 |
| Mar 31, 2024 | -10.70 |
| Dec 31, 2023 | -0.70 |
| Dec 31, 2022 | 417.03 |
| Jun 30, 2022 | -8,259.02 |
| Mar 31, 2022 | -3,427.93 |
| Dec 31, 2021 | -676.09 |
| Sep 30, 2021 | -6.45 |
| Jun 30, 2021 | -4.51 |
| Mar 31, 2021 | -5.90 |